Controlled drug release from antibiotic-loaded layered double hydroxide coatings on porous titanium implants in a mouse model

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Muhammad Badar
  • Muhammad Imran Rahim
  • Marc Kieke
  • Thomas Ebel
  • Manfred Rohde
  • Hansjörg Hauser
  • Peter Behrens
  • Peter P. Mueller

Research Organisations

External Research Organisations

  • Helmholtz Centre for Infection Research (HZI)
  • Gomal University
  • Helmholtz Zentrum Geesthacht Centre for Materials and Coastal Research
View graph of relations

Details

Original languageEnglish
Pages (from-to)2141-2149
Number of pages9
JournalJournal of Biomedical Materials Research - Part A
Volume103
Issue number6
Publication statusPublished - 24 Oct 2014

Abstract

As an alternative to degradable organic coatings the possibility of using layered double hydroxides (LDHs) to generate implant coatings for controlled drug delivery was evaluated in vivo and in vitro. Coatings prepared from LDH suspensions dissolved slowly and appeared compatible with cultured cells. LDH coatings loaded with an antibiotic resulted in antibacterial effects in vitro. The LDH coating prolonged the drug release period and improved the proliferation of adherent cells in comparison to pure drug coatings. However, during incubation in physiological solutions the LDH coatings became brittle and pieces occasionally detached from the surface. For stress protection porous titanium implants were investigated as a substrate for the coatings. The pores prevented premature detachment of the coatings. To evaluate the coated porous implants in vivo a mouse model was established. To monitor bacterial infection of implants noninvasive in vivo imaging was used to monitor luminescently labeled Pseudomonas aeruginosa. In this model porous implants with antibiotic-loaded LDH coatings could antagonize bacterial infections for over 1 week. The findings provide evidence that delayed drug delivery from LDH coatings could be feasible in combination with structured implant surfaces.

Keywords

    bacterial biofilm, degradable implant coating, implant infection, layered double hydroxides, local drug delivery

ASJC Scopus subject areas

Cite this

Controlled drug release from antibiotic-loaded layered double hydroxide coatings on porous titanium implants in a mouse model. / Badar, Muhammad; Rahim, Muhammad Imran; Kieke, Marc et al.
In: Journal of Biomedical Materials Research - Part A, Vol. 103, No. 6, 24.10.2014, p. 2141-2149.

Research output: Contribution to journalArticleResearchpeer review

Badar M, Rahim MI, Kieke M, Ebel T, Rohde M, Hauser H et al. Controlled drug release from antibiotic-loaded layered double hydroxide coatings on porous titanium implants in a mouse model. Journal of Biomedical Materials Research - Part A. 2014 Oct 24;103(6):2141-2149. doi: 10.1002/jbm.a.35358
Download
@article{7b111a033c2440a99f70d6cd8309332b,
title = "Controlled drug release from antibiotic-loaded layered double hydroxide coatings on porous titanium implants in a mouse model",
abstract = "As an alternative to degradable organic coatings the possibility of using layered double hydroxides (LDHs) to generate implant coatings for controlled drug delivery was evaluated in vivo and in vitro. Coatings prepared from LDH suspensions dissolved slowly and appeared compatible with cultured cells. LDH coatings loaded with an antibiotic resulted in antibacterial effects in vitro. The LDH coating prolonged the drug release period and improved the proliferation of adherent cells in comparison to pure drug coatings. However, during incubation in physiological solutions the LDH coatings became brittle and pieces occasionally detached from the surface. For stress protection porous titanium implants were investigated as a substrate for the coatings. The pores prevented premature detachment of the coatings. To evaluate the coated porous implants in vivo a mouse model was established. To monitor bacterial infection of implants noninvasive in vivo imaging was used to monitor luminescently labeled Pseudomonas aeruginosa. In this model porous implants with antibiotic-loaded LDH coatings could antagonize bacterial infections for over 1 week. The findings provide evidence that delayed drug delivery from LDH coatings could be feasible in combination with structured implant surfaces.",
keywords = "bacterial biofilm, degradable implant coating, implant infection, layered double hydroxides, local drug delivery",
author = "Muhammad Badar and Rahim, {Muhammad Imran} and Marc Kieke and Thomas Ebel and Manfred Rohde and Hansj{\"o}rg Hauser and Peter Behrens and Mueller, {Peter P.}",
year = "2014",
month = oct,
day = "24",
doi = "10.1002/jbm.a.35358",
language = "English",
volume = "103",
pages = "2141--2149",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "1549-3296",
publisher = "Heterocorporation",
number = "6",

}

Download

TY - JOUR

T1 - Controlled drug release from antibiotic-loaded layered double hydroxide coatings on porous titanium implants in a mouse model

AU - Badar, Muhammad

AU - Rahim, Muhammad Imran

AU - Kieke, Marc

AU - Ebel, Thomas

AU - Rohde, Manfred

AU - Hauser, Hansjörg

AU - Behrens, Peter

AU - Mueller, Peter P.

PY - 2014/10/24

Y1 - 2014/10/24

N2 - As an alternative to degradable organic coatings the possibility of using layered double hydroxides (LDHs) to generate implant coatings for controlled drug delivery was evaluated in vivo and in vitro. Coatings prepared from LDH suspensions dissolved slowly and appeared compatible with cultured cells. LDH coatings loaded with an antibiotic resulted in antibacterial effects in vitro. The LDH coating prolonged the drug release period and improved the proliferation of adherent cells in comparison to pure drug coatings. However, during incubation in physiological solutions the LDH coatings became brittle and pieces occasionally detached from the surface. For stress protection porous titanium implants were investigated as a substrate for the coatings. The pores prevented premature detachment of the coatings. To evaluate the coated porous implants in vivo a mouse model was established. To monitor bacterial infection of implants noninvasive in vivo imaging was used to monitor luminescently labeled Pseudomonas aeruginosa. In this model porous implants with antibiotic-loaded LDH coatings could antagonize bacterial infections for over 1 week. The findings provide evidence that delayed drug delivery from LDH coatings could be feasible in combination with structured implant surfaces.

AB - As an alternative to degradable organic coatings the possibility of using layered double hydroxides (LDHs) to generate implant coatings for controlled drug delivery was evaluated in vivo and in vitro. Coatings prepared from LDH suspensions dissolved slowly and appeared compatible with cultured cells. LDH coatings loaded with an antibiotic resulted in antibacterial effects in vitro. The LDH coating prolonged the drug release period and improved the proliferation of adherent cells in comparison to pure drug coatings. However, during incubation in physiological solutions the LDH coatings became brittle and pieces occasionally detached from the surface. For stress protection porous titanium implants were investigated as a substrate for the coatings. The pores prevented premature detachment of the coatings. To evaluate the coated porous implants in vivo a mouse model was established. To monitor bacterial infection of implants noninvasive in vivo imaging was used to monitor luminescently labeled Pseudomonas aeruginosa. In this model porous implants with antibiotic-loaded LDH coatings could antagonize bacterial infections for over 1 week. The findings provide evidence that delayed drug delivery from LDH coatings could be feasible in combination with structured implant surfaces.

KW - bacterial biofilm

KW - degradable implant coating

KW - implant infection

KW - layered double hydroxides

KW - local drug delivery

UR - http://www.scopus.com/inward/record.url?scp=84928523091&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.35358

DO - 10.1002/jbm.a.35358

M3 - Article

C2 - 25345717

AN - SCOPUS:84928523091

VL - 103

SP - 2141

EP - 2149

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 1549-3296

IS - 6

ER -